630 results
Structural cardiac interventions in patients with heart failure
27 Aug 2024
The review aims to address the unmet needs in heart failure (HF) management, particularly in patients where structural heart disease coexists with HF and limits the effectiveness of guideline-directed medical therapy (GDMT).

Reviewer

MATTERHORN - Transcatheter versus surgical mitral valve repair in patients with heart failure and secondary mitral regurgitation
01 Sep 2024
Yohei Ohno provides his takeaways from the results of the MATTERHORN trial presented by Volker Rudolph at the ESC Congress 2024 in London.

Author

RESHAPE-HF2 - Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure
01 Sep 2024
Nicola Ryan provides her take on the RESHAPE-HF2 trial presented by Stefan Anker at the ESC Congress 2024 in London and simultaneously published in the NEJM.
The RESHAPE-HF 2 trial is a prospective randomised control trial comparing transcatheter mitral valve repair (TEER) and guideline-directed medical therapy to guideline-directed medical...

Author

MitrAI score: machine learning models to predict mortality at 12, 24, 36 and 48 months in patients with primary and secondary MR treated by TEER
31 Aug 2024
Jonathan Curio provides his take on the MitrAI score study which was presented by Luigi Biasco at ESC Congress 2024 in London.

Author

PCRonline @ ESC Congress 2024: the interventional cardiology perspective!
26 Jul 2024
What was new and hot in interventional cardiology at #ESCCongress 2024!

Robotic-assisted transcatheter edge-to-edge repair with MitraClip G4
05 Jul 2024
This case report demonstrates, for the first time, the feasibility of mitral TEER with a robotic-assisted approach, using the Abbott MitraClip G4 system, potentially paving the way for future applications in structural heart and endovascular interventions.

Author

Author

Author

New York Valves 2024: Everything you need to know in a nutshell
11 Jun 2024
Alex Sticchi provides his take on the trials which were presented at New York Valves 2024, offering a concise summary, a short description and final thoughts.

Author

Meet the EuroPCR 2024 Andreas Grüntzig Ethica Awardees
16 May 2024
Ottavio Alfieri and Frederick St Goar received the award for their important work on developing new opportunities for expanding indications of interventions targeting mitral regurgitation in patients with heart failure, with benefits including mortality reduction in selected cases. Find out more about the achievements of this...

PASCAL Precision system simulation showcase: grasp the difference!
16 May 2024 – From EuroPCR 2024
In this EuroPCR 2024 session, explore a transcatheter edge-to-edge mitral valve repair case, delve into discussions backed by simulation, evidence, and real-world cases to understand atraumatic clasp and closure techniques and predictable implant release. Additionally, gain insights into real-world evidence for tricuspid TEER from the EuroTR trial...

When mitral valve intervention goes wrong
16 May 2024 – From EuroPCR 2024
This session examines various complications that can arise during mitral valve interventions, such as iatrogenic aortic root perforation, unexpected leakage, and other challenging scenarios. The presenters share their experiences in managing these complications and the strategies they employed to address them. The session emphasizes the importance...
